Potential for regenerative medicine and cancer research earns doctoral student Ido Sagi a Kaye Innovation Award
Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their ability to turn into any cell in the human body, are essential to the future prevention and treatment of disease.
One set or two? Diploid versus haploid cells
Most of the cells in our body are diploid, which means they carry two sets of chromosomes — one from each parent. Until now, scientists have only succeeded in creating haploid embryonic stem cells — which contain a single set of chromosomes — in non-human mammals such as mice, rats and monkeys. However, scientists have long sought to isolate and replicate these haploid ESCs in humans, which would allow them to work with one set of human chromosomes as opposed to a mixture from both parents.
This milestone was finally reached when Ido Sagi, working as a PhD student at the Hebrew University of Jerusalem’s Azrieli Center for Stem Cells and Genetic Research, led research that yielded the first successful isolation and maintenance of haploid embryonic stem cells in humans. Unlike in mice, these haploid stem cells were able to differentiate into many other cell types, such as brain, heart and pancreas, while retaining a single set of chromosomes.
With Prof. Nissim Benvenisty, Director of the Azrieli Center, Sagi showed that this new human stem cell type will play an important role in human genetic and medical research. It will aid our understanding of human development – for example, why we reproduce sexually instead of from a single parent. It will make genetic screening easier and more precise, by allowing the examination of single sets of chromosomes. And it is already enabling the study of resistance to chemotherapy drugs, with implications for cancer therapy.
Diagnostic kits for personalized medicine
Based on this research, Yissum, the Technology Transfer arm of the Hebrew University, launched the company New Stem, which is developing a diagnostic kit for predicting resistance to chemotherapy treatments. By amassing a broad library of human pluripotent stem cells with different mutations and genetic makeups, NewStem plans to develop diagnostic kits for personalized medication and future therapeutic and reproductive products.
The Latest on: Haploid embryonic stem cells
- Dr. Craig S. Niederbergeron March 18, 2020 at 5:00 pm
Dr. Craig S. Niederberger is an urologist in Chicago, Illinois and is affiliated with University of Illinois Hospital. He received his medical degree from University of Pittsburgh School of ...
- Genetic Screens in Human Cells Using the CRISPR-Cas9 Systemon March 5, 2020 at 4:00 pm
Insertional mutagenesis screens in cell lines that are near-haploid or carry Blm mutations, which cause frequent somatic crossing-over, have proven powerful but are not applicable to most cell lines ...
- Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carrierson March 3, 2020 at 4:00 pm
Most of the identified CNVs were subchromosomal haploid losses, consistent with the widespread pattern of losses observed in BRCA2-associated breast cancer (Fig. 2A and fig. S2B) (1). In some cases, ...
- Controlled ploidy reduction of pluripotent 4n cells generates 2n cells during mouse embryo developmenton March 3, 2020 at 4:00 pm
Pluripotent 4n cell lines can be generated by heterotypic cell fusion between mouse embryonic stem cells (ESCs) and somatic cells in vitro (13, 14). This leads to epigenetic reprogramming of the ...
- Generation of human androgenetic induced pluripotent stem cellson February 27, 2020 at 2:13 am
AgHiPSCs might be an attractive alternative source of human androgenetic embryonic stem cells. Furthermore, AgHiPSCs can be used in regenerative medicine, for analysis of genomic imprinting ...
- In vitro testicular organogenesis from human fetal gonads produces fertilization-competent spermatidson February 20, 2020 at 4:00 pm
Remarkably, in vitro-derived haploid spermatids have undergone meiotic ... 2: Sertoli and Leydig cell maturation during human testis organogenesis in vitro. Fig. 3: Successful spermatogenesis ...
- PloS oneon February 13, 2020 at 4:00 pm
Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by α-particles radiation.
- Cell differentiationon August 6, 2019 at 11:19 pm
Cells at early stages in the development of the embryo are stem cells. If cells are removed from the embryo – called embryonic stem cells – they will differentiate into any cell type.
- How do organisms grow and develop? - OCR 21Con July 30, 2019 at 8:09 am
How many new cells are produced during meiosis? A cell found in the embryo that can differentiate into any type of cell A cell in a meristem that can differentiate into any type of cell A cell in ...
- Bioinformatics as a Serviceon January 17, 2019 at 12:21 am
In this study of Snyder Lab, molecular mechanisms underlying this drug induced developmental toxicity in cardiomyocyte differentiation were investigated using both human induced pluripotent stem cells ...
via Google News and Bing News